We support several promising research projects (epidemiological, fundamental, preclinical), led by INSERM, CNRS and university teams, which lack resources, and share our findings. Their work focuses in particular on brainstem tumors, childhood liver cancer, kidney cancer, rhabdomyosarcoma, neuroblastoma and, more broadly, on the repositioning of drugs in pediatric oncology.
